{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:50:51Z","timestamp":1791222651287,"version":"4.1.0"},"reference-count":170,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004084","name":"Korea Science and Engineering Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004084","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"publisher","award":["2014R1A2A10052872"],"award-info":[{"award-number":["2014R1A2A10052872"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"publisher","award":["CA129038"],"award-info":[{"award-number":["CA129038"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.semcancer.2017.07.007","type":"journal-article","created":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T03:16:48Z","timestamp":1501557408000},"page":"142-151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"special_numbering":"C","title":["Role of Forkhead Box Class O proteins in cancer progression and metastasis"],"prefix":"10.1016","volume":"50","author":[{"given":"Chang Geun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyemin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nehal","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharavan","family":"Ramachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itishree","family":"Kaushik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangeeta","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay K.","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.semcancer.2017.07.007_bib0005","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/gcc.10264","article-title":"Multistage carcinogenesis and the incidence of human cancer","volume":"38","author":"Moolgavkar","year":"2003","journal-title":"Genes. Chromosomes Cancer"},{"issue":"5","key":"10.1016\/j.semcancer.2017.07.007_bib0010","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.semcancer.2008.03.019","article-title":"The microenvironments of multistage carcinogenesis","volume":"18","author":"Laconi","year":"2008","journal-title":"Semin. Cancer Biol."},{"issue":"6","key":"10.1016\/j.semcancer.2017.07.007_bib0015","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrc1098","article-title":"The pathogenesis of cancer metastasis: the \u2018seed and soil' hypothesis revisited","volume":"3","author":"Fidler","year":"2003","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"10.1016\/j.semcancer.2017.07.007_bib0020","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1080\/15384047.2016.1218721","volume":"17","author":"Erratum","year":"2016","journal-title":"Cancer Biol. Ther."},{"issue":"2","key":"10.1016\/j.semcancer.2017.07.007_bib0025","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","article-title":"Tumor metastasis: molecular insights and evolving paradigms","volume":"147","author":"Valastyan","year":"2011","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.semcancer.2017.07.007_bib0030","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1172\/JCI38019","article-title":"Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease","volume":"119","author":"Acloque","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.semcancer.2017.07.007_bib0035","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","article-title":"Epithelial-mesenchymal transitions in development and disease","volume":"139","author":"Thiery","year":"2009","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.semcancer.2017.07.007_bib0040","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10555-006-7886-9","article-title":"Matrix metalloproteinases and tumor metastasis","volume":"25","author":"Deryugina","year":"2006","journal-title":"Cancer Metastasis Rev."},{"issue":"6","key":"10.1016\/j.semcancer.2017.07.007_bib0045","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s00018-015-2112-y","article-title":"FoxO transcription factors in cancer development and therapy","volume":"73","author":"Coomans de Brachene","year":"2016","journal-title":"Cell. Mol. Life Sci.: CMLS"},{"issue":"3","key":"10.1016\/j.semcancer.2017.07.007_bib0050","doi-asserted-by":"crossref","first-page":"e0121474","DOI":"10.1371\/journal.pone.0121474","article-title":"The PAX3-FoxO1 fusion protein present in rhabdomyosarcoma interferes with normal FoxO activity and the TGF-beta pathway","volume":"10","author":"Schmitt-Ney","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.semcancer.2017.07.007_bib0055","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3892\/or.2014.3357","article-title":"Targeting forkhead box transcription factors FOXM1 and FoxO in leukemia (Review)","volume":"32","author":"Zhu","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.semcancer.2017.07.007_bib0060","doi-asserted-by":"crossref","first-page":"e2046","DOI":"10.1038\/cddis.2015.396","article-title":"FoxO3 suppresses myc-driven lymphomagenesis","volume":"6","author":"Vandenberg","year":"2016","journal-title":"Cell. Death. Dis."},{"key":"10.1016\/j.semcancer.2017.07.007_bib0065","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1186\/1471-2407-14-378","article-title":"The transcription factor FoxO4 is down-regulated and inhibits tumor proliferation and metastasis in gastric cancer","volume":"14","author":"Su","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.semcancer.2017.07.007_bib0070","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1186\/1471-2407-13-468","article-title":"FoxO\/TXNIP pathway is involved in the suppression of hepatocellular carcinoma growth by glutamate antagonist MK-801","volume":"13","author":"Yamaguchi","year":"2013","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.semcancer.2017.07.007_bib0075","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/iep.12187","article-title":"Expression of FOXM1 and related proteins in breast cancer molecular subtypes","volume":"97","author":"Lee","year":"2016","journal-title":"Int. J. Exp. Pathol."},{"issue":"3","key":"10.1016\/j.semcancer.2017.07.007_bib0080","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.cellsig.2015.01.001","article-title":"FoxO3a modulates WNT\/beta-catenin signaling and suppresses epithelial-to-mesenchymal transition in prostate cancer cells","volume":"27","author":"Liu","year":"2015","journal-title":"Cell. Signal."},{"issue":"8","key":"10.1016\/j.semcancer.2017.07.007_bib0085","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1097\/CAD.0000000000000117","article-title":"FoxO3a mediates the cytotoxic effects of cisplatin in lung cancer cells","volume":"25","author":"Liu","year":"2014","journal-title":"Anticancer Drugs"},{"issue":"3","key":"10.1016\/j.semcancer.2017.07.007_bib0090","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/ng1193-230","article-title":"3rd, B.S., Emanuel, G., Rovera, F.G., Barr, Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma","volume":"5","author":"Galili","year":"1993","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.semcancer.2017.07.007_bib0095","doi-asserted-by":"crossref","first-page":"253","DOI":"10.4161\/cbt.12.4.15954","article-title":"FoxO family members in cancer","volume":"12","author":"Zhang","year":"2011","journal-title":"Cancer Biol. Ther."},{"issue":"4","key":"10.1016\/j.semcancer.2017.07.007_bib0100","doi-asserted-by":"crossref","first-page":"R113","DOI":"10.1016\/j.cub.2007.01.008","article-title":"FoxO transcription factors","volume":"17","author":"Carter","year":"2007","journal-title":"Curr. Biol."},{"issue":"Pt. 15","key":"10.1016\/j.semcancer.2017.07.007_bib0105","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1242\/jcs.001222","article-title":"Dynamic FoxO transcription factors","volume":"120","author":"Huang","year":"2007","journal-title":"J. Cell Sci."},{"issue":"Pt. 2","key":"10.1016\/j.semcancer.2017.07.007_bib0110","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1042\/bj3490629","article-title":"Identification of the differential distribution patterns of mRNAs and consensus binding sequences for mouse DAF-16 homologues","volume":"349","author":"Furuyama","year":"2000","journal-title":"Biochem. J"},{"issue":"6","key":"10.1016\/j.semcancer.2017.07.007_bib0115","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s003350020002","article-title":"Identification and characterization of members of the FKHR (FOX O) subclass of winged-helix transcription factors in the mouse","volume":"12","author":"Biggs","year":"2001","journal-title":"Mamm. Genome"},{"issue":"13","key":"10.1016\/j.semcancer.2017.07.007_bib0120","doi-asserted-by":"crossref","first-page":"7421","DOI":"10.1073\/pnas.96.13.7421","article-title":"Protein kinase B\/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1","volume":"96","author":"Biggs","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"24","key":"10.1016\/j.semcancer.2017.07.007_bib0125","doi-asserted-by":"crossref","first-page":"17184","DOI":"10.1074\/jbc.274.24.17184","article-title":"Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence","volume":"274","author":"Guo","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"50","key":"10.1016\/j.semcancer.2017.07.007_bib0130","doi-asserted-by":"crossref","first-page":"7410","DOI":"10.1038\/sj.onc.1209086","article-title":"FoxO transcription factors at the interface between longevity and tumor suppression","volume":"24","author":"Greer","year":"2005","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.semcancer.2017.07.007_bib0135","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/nrm2190","article-title":"Stressing the role of FoxO proteins in lifespan and disease","volume":"8","author":"van der Horst","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"6654","key":"10.1016\/j.semcancer.2017.07.007_bib0140","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/40194","article-title":"The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans","volume":"389","author":"Ogg","year":"1997","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.semcancer.2017.07.007_bib0145","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1038\/onc.2008.20","article-title":"Structure\/function relationships underlying regulation of FoxO transcription factors","volume":"27","author":"Obsil","year":"2008","journal-title":"Oncogene"},{"issue":"16","key":"10.1016\/j.semcancer.2017.07.007_bib0150","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1038\/onc.2008.24","article-title":"FoxOs, cancer and regulation of apoptosis","volume":"27","author":"Fu","year":"2008","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.semcancer.2017.07.007_bib0155","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.bbamcr.2011.06.002","article-title":"FoxO transcription factors; Regulation by Akt and 14-3-3 proteins","volume":"1813","author":"Tzivion","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"issue":"27","key":"10.1016\/j.semcancer.2017.07.007_bib0160","doi-asserted-by":"crossref","first-page":"10042","DOI":"10.1073\/pnas.0400593101","article-title":"Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity","volume":"101","author":"Daitoku","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.semcancer.2017.07.007_bib0165","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/bfgp\/ell028","article-title":"Histone acetylation in gene regulation","volume":"5","author":"Verdone","year":"2006","journal-title":"Briefings Funct. Genomics Proteomics"},{"issue":"11","key":"10.1016\/j.semcancer.2017.07.007_bib0170","doi-asserted-by":"crossref","first-page":"10264","DOI":"10.1074\/jbc.M408748200","article-title":"SIRT1 deacetylation and repression of p300 involves lysine residues 1020\/1024 within the cell cycle regulatory domain 1","volume":"280","author":"Bouras","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.semcancer.2017.07.007_bib0175","first-page":"237","article-title":"SIRT1 is critical regulator of FoxO-mediated transcription in response to oxidative stress","volume":"16","author":"Kobayashi","year":"2005","journal-title":"Int. J. Mol. Med."},{"issue":"3","key":"10.1016\/j.semcancer.2017.07.007_bib0180","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1091\/mbc.e08-06-0647","article-title":"SIRT2 suppresses adipocyte differentiation by deacetylating FoxO1 and enhancing FoxO1's repressive interaction with PPARgamma","volume":"20","author":"Wang","year":"2009","journal-title":"Mol. Biol. Cell"},{"issue":"9","key":"10.1016\/j.semcancer.2017.07.007_bib0185","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nchembio.194","article-title":"Redox-sensitive cysteines bridge p300\/CBP-mediated acetylation and FoxO4 activity","volume":"5","author":"Dansen","year":"2009","journal-title":"Nat. Chem. Biol."},{"issue":"7","key":"10.1016\/j.semcancer.2017.07.007_bib0190","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/ncb2069","article-title":"Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity","volume":"12","author":"Zhao","year":"2010","journal-title":"Nat. Cell Biol."},{"issue":"32","key":"10.1016\/j.semcancer.2017.07.007_bib0195","doi-asserted-by":"crossref","first-page":"11278","DOI":"10.1073\/pnas.0502738102","article-title":"Acetylation of Foxo1 alters its DNA-binding ability and sensitivity to phosphorylation","volume":"102","author":"Matsuzaki","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"41","key":"10.1016\/j.semcancer.2017.07.007_bib0200","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.1038\/onc.2008.248","article-title":"The role of PTEN signaling perturbations in cancer and in targeted therapy","volume":"27","author":"Keniry","year":"2008","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.semcancer.2017.07.007_bib0205","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1177\/1947601911407325","article-title":"PTEN tumor suppressor network in PI3K-Akt pathway control","volume":"1","author":"Georgescu","year":"2010","journal-title":"Genes Cancer"},{"issue":"2","key":"10.1016\/j.semcancer.2017.07.007_bib0210","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.pharmthera.2013.12.004","article-title":"Molecular targets for cancer therapy in the PI3 K\/Akt\/mTOR pathway","volume":"142","author":"Polivka,","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.semcancer.2017.07.007_bib0215","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1146\/annurev-med-062913-051343","article-title":"The PI3\u202fK\/Akt pathway as a target for cancer treatment","volume":"67","author":"Mayer","year":"2016","journal-title":"Annu. Rev. Med."},{"issue":"23","key":"10.1016\/j.semcancer.2017.07.007_bib0220","doi-asserted-by":"crossref","first-page":"15982","DOI":"10.1074\/jbc.274.23.15982","article-title":"Insulin stimulates phosphorylation of the forkhead transcription factor FKHR on serine 253 through a Wortmannin-sensitive pathway","volume":"274","author":"Nakae","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"5666","key":"10.1016\/j.semcancer.2017.07.007_bib0225","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1126\/science.1094637","article-title":"Stress-dependent regulation of FoxO transcription factors by the SIRT1 deacetylase","volume":"303","author":"Brunet","year":"2004","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.semcancer.2017.07.007_bib0230","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0092-8674(00)80595-4","article-title":"Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor","volume":"96","author":"Brunet","year":"1999","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.semcancer.2017.07.007_bib0235","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1128\/MCB.22.7.2025-2036.2002","article-title":"Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors","volume":"22","author":"Kops","year":"2002","journal-title":"Mol. Cell. Biol."},{"issue":"Pt. 3","key":"10.1016\/j.semcancer.2017.07.007_bib0240","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1042\/bj3540605","article-title":"Roles of the forkhead in rhabdomyosarcoma (FKHR) phosphorylation sites in regulating 14-3-3 binding, transactivation and nuclear targetting","volume":"354","author":"Rena","year":"2001","journal-title":"Biochem. J"},{"issue":"6","key":"10.1016\/j.semcancer.2017.07.007_bib0245","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1189\/jlb.1202629","article-title":"Decisions on life and death: foxO Forkhead transcription factors are in command when PKB\/Akt is off duty","volume":"73","author":"Burgering","year":"2003","journal-title":"J. Leukoc. Biol."},{"issue":"11","key":"10.1016\/j.semcancer.2017.07.007_bib0250","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.bbamcr.2011.03.010","article-title":"Akt FoxO and regulation of apoptosis","volume":"1813","author":"Zhang","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.semcancer.2017.07.007_bib0255","doi-asserted-by":"crossref","first-page":"6605","DOI":"10.4238\/2015.June.18.3","article-title":"FoxO1 is a tumor suppressor in cervical cancer","volume":"14","author":"Zhang","year":"2015","journal-title":"Genet. Mol. Res.: GMR"},{"issue":"9","key":"10.1016\/j.semcancer.2017.07.007_bib0260","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1158\/0008-5472.CAN-10-2603","article-title":"FoxO1 inhibits Runx2 transcriptional activity and prostate cancer cell migration and invasion","volume":"71","author":"Zhang","year":"2011","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.semcancer.2017.07.007_bib0265","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1111\/cmi.12298","article-title":"Forkhead box O3 (FoxO3) transcription factor mediates apoptosis in BCG-infected macrophages","volume":"16","author":"Haoues","year":"2014","journal-title":"Cell. Microbiol."},{"issue":"3","key":"10.1016\/j.semcancer.2017.07.007_bib0270","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.3892\/mmr.2016.4789","article-title":"Overexpression of FoxO4 induces apoptosis of clear-cell renal carcinoma cells through downregulation of Bim","volume":"13","author":"Wang","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"14","key":"10.1016\/j.semcancer.2017.07.007_bib0275","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1038\/sj.onc.1208421","article-title":"Direct transcriptional regulation of Bim by FoxO3a mediates STI571-induced apoptosis in Bcr-Abl-expressing cells","volume":"24","author":"Essafi","year":"2005","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.semcancer.2017.07.007_bib0280","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0968-0004(02)02113-8","article-title":"Cell cycle and death control: long live Forkheads","volume":"27","author":"Burgering","year":"2002","journal-title":"Trends Biochem. Sci."},{"issue":"11","key":"10.1016\/j.semcancer.2017.07.007_bib0285","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nrm2245","article-title":"Autophagy: from phenomenology to molecular understanding in less than a decade","volume":"8","author":"Klionsky","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.semcancer.2017.07.007_bib0290","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S1534-5807(04)00099-1","article-title":"Development by self-digestion: molecular mechanisms and biological functions of autophagy","volume":"6","author":"Levine","year":"2004","journal-title":"Dev. Cell"},{"issue":"2","key":"10.1016\/j.semcancer.2017.07.007_bib0295","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.3390\/ijms15023145","article-title":"Autophagic cell death and cancer","volume":"15","author":"Shimizu","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"16","key":"10.1016\/j.semcancer.2017.07.007_bib0300","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1038\/sj.onc.1207521","article-title":"Autophagy as a cell death and tumor suppressor mechanism","volume":"23","author":"Gozuacik","year":"2004","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.semcancer.2017.07.007_bib0305","doi-asserted-by":"crossref","first-page":"C444","DOI":"10.1152\/ajpcell.00188.2015","article-title":"Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: cell and Molecular Processes in Cancer Metastasis","volume":"309","author":"Yeung","year":"2015","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"34","key":"10.1016\/j.semcancer.2017.07.007_bib0310","doi-asserted-by":"crossref","first-page":"35522","DOI":"10.18632\/oncotarget.5849","article-title":"The molecular effect of metastasis suppressors on Src signaling and tumorigenesis: new therapeutic targets","volume":"6","author":"Liu","year":"2015","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.semcancer.2017.07.007_bib0315","first-page":"557","article-title":"Epithelial-mesenchymal transition in colorectal cancer metastasis: a system review, Pathology","volume":"211","author":"Cao","year":"2015","journal-title":"Res. Pract."},{"issue":"2","key":"10.1016\/j.semcancer.2017.07.007_bib0320","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4103\/0970-9371.182529","article-title":"Effusion cytomorphology of small round cell tumors","volume":"33","author":"Ikeda","year":"2016","journal-title":"J. Cytol."},{"issue":"24","key":"10.1016\/j.semcancer.2017.07.007_bib0325","doi-asserted-by":"crossref","first-page":"7471","DOI":"10.1158\/0008-5472.CAN-11-0924","article-title":"PAX3-FoxO1 induces cannabinoid receptor 1 to enhance cell invasion and metastasis","volume":"71","author":"Marshall","year":"2011","journal-title":"Cancer Res."},{"issue":"35","key":"10.1016\/j.semcancer.2017.07.007_bib0330","doi-asserted-by":"crossref","first-page":"22330","DOI":"10.1074\/jbc.272.35.22330","article-title":"A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. Evidence for a new model of receptor\/ligand interactions","volume":"272","author":"Bouaboula","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.semcancer.2017.07.007_bib0335","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1200\/JCO.2002.03.137","article-title":"PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group","volume":"20","author":"Sorensen","year":"2002","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.semcancer.2017.07.007_bib0340","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/bjc.2015.273","article-title":"Loss of FoxO1 promotes gastric tumour growth and metastasis through upregulation of human epidermal growth factor receptor 2\/neu expression","volume":"113","author":"Ko","year":"2015","journal-title":"Br. J. Cancer"},{"issue":"7","key":"10.1016\/j.semcancer.2017.07.007_bib0345","doi-asserted-by":"crossref","first-page":"7195","DOI":"10.1007\/s13277-014-1913-1","article-title":"Inhibition of FoxO1 nuclear exclusion prevents metastasis of glioblastoma","volume":"35","author":"Chen","year":"2014","journal-title":"Tumour Biol."},{"issue":"10","key":"10.1016\/j.semcancer.2017.07.007_bib0350","doi-asserted-by":"crossref","first-page":"9987","DOI":"10.1007\/s13277-014-2067-x","article-title":"Epidermal growth factor induces FoxO1 nuclear exclusion to activate MMP7-mediated metastasis of larynx carcinoma","volume":"35","author":"Ding","year":"2014","journal-title":"Tumour Biol."},{"issue":"8","key":"10.1016\/j.semcancer.2017.07.007_bib0355","doi-asserted-by":"crossref","first-page":"902","DOI":"10.4161\/cc.6.8.4122","article-title":"CDK2 and FoxO1: a fork in the road for cell fate decisions","volume":"6","author":"Huang","year":"2007","journal-title":"ABBV Cell Cycle"},{"issue":"5797","key":"10.1016\/j.semcancer.2017.07.007_bib0360","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1126\/science.1130512","article-title":"CDK2-dependent phosphorylation of FoxO1 as an apoptotic response to DNA damage","volume":"314","author":"Huang","year":"2006","journal-title":"Science"},{"issue":"16","key":"10.1016\/j.semcancer.2017.07.007_bib0365","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1128\/MCB.05523-11","article-title":"Cdc25A regulates matrix metalloprotease 1 through Foxo1 and mediates metastasis of breast cancer cells","volume":"31","author":"Feng","year":"2011","journal-title":"Mol. Cell. Biol."},{"issue":"6","key":"10.1016\/j.semcancer.2017.07.007_bib0370","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1172\/JCI9174","article-title":"Role of the Cdc25A phosphatase in human breast cancer","volume":"106","author":"Cangi","year":"2000","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.semcancer.2017.07.007_bib0375","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nrc2169","article-title":"CDC25 phosphatases in cancer cells: key players? Good targets?","volume":"7","author":"Boutros","year":"2007","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.semcancer.2017.07.007_bib0380","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1158\/0008-5472.CAN-07-5983","article-title":"CDC25A phosphatase: a rate-limiting oncogene that determines genomic stability","volume":"68","author":"Ray","year":"2008","journal-title":"Cancer Res."},{"issue":"21","key":"10.1016\/j.semcancer.2017.07.007_bib0385","doi-asserted-by":"crossref","first-page":"6813","DOI":"10.1158\/1078-0432.CCR-08-0626","article-title":"Aberrant Polo-like kinase 1-Cdc25A pathway in metastatic hepatocellular carcinoma","volume":"14","author":"Wang","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.semcancer.2017.07.007_bib0390","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s13277-010-0075-z","article-title":"CDC 25A gene 263C\/T, \u2212350C\/T, and \u221251C\/G polymorphisms in breast carcinoma","volume":"31","author":"Karagoz","year":"2010","journal-title":"Tumour Biol."},{"issue":"9","key":"10.1016\/j.semcancer.2017.07.007_bib0395","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1593\/neo.11594","article-title":"Inhibition of cyclin-dependent kinase phosphorylation of FoxO1 and prostate cancer cell growth by a peptide derived from FoxO1","volume":"13","author":"Lu","year":"2011","journal-title":"Neoplasia"},{"issue":"5\u20136","key":"10.1016\/j.semcancer.2017.07.007_bib0400","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.cytogfr.2011.11.006","article-title":"Few Smad proteins and many Smad-interacting proteins yield multiple functions and action modes in TGFbeta\/BMP signaling in vivo","volume":"22","author":"Conidi","year":"2011","journal-title":"Cytokine Growth Factor Rev."},{"issue":"10","key":"10.1016\/j.semcancer.2017.07.007_bib0405","doi-asserted-by":"crossref","first-page":"7918","DOI":"10.18632\/oncotarget.3486","article-title":"MicroRNA-200a suppresses metastatic potential of side population cells in human hepatocellular carcinoma by decreasing ZEB2","volume":"6","author":"Yang","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.semcancer.2017.07.007_bib0410","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.18632\/oncotarget.13786","article-title":"FoxO1 inhibits the invasion and metastasis of hepatocellular carcinoma by reversing ZEB2-induced epithelial-mesenchymal transition","volume":"8","author":"Dong","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.semcancer.2017.07.007_bib0415","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/hep.26735","article-title":"Forkhead box Q1 promotes hepatocellular carcinoma metastasis by transactivating ZEB2 and VersicanV1 expression","volume":"59","author":"Xia","year":"2014","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.semcancer.2017.07.007_bib0420","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/carcin\/bgs005","article-title":"ZEB2 upregulates integrin alpha5 expression through cooperation with Sp1 to induce invasion during epithelial-mesenchymal transition of human cancer cells","volume":"33","author":"Nam","year":"2012","journal-title":"Carcinogenesis"},{"issue":"20","key":"10.1016\/j.semcancer.2017.07.007_bib0425","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1007\/s00018-012-1122-2","article-title":"EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness","volume":"69","author":"Sanchez-Tillo","year":"2012","journal-title":"Cell. Mol. Life Sci.: CMLS"},{"issue":"8","key":"10.1016\/j.semcancer.2017.07.007_bib0430","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/MCG.0b013e3182557307","article-title":"Advances in the management of HER2-positive advanced gastric and gastroesophageal junction cancer","volume":"46","author":"Bang","year":"2012","journal-title":"J. Clin. Gastroenterol."},{"issue":"49","key":"10.1016\/j.semcancer.2017.07.007_bib0435","doi-asserted-by":"crossref","first-page":"5680","DOI":"10.1038\/sj.onc.1203924","article-title":"Tyrosine kinases and gastric cancer","volume":"19","author":"Lin","year":"2000","journal-title":"Oncogene"},{"issue":"13","key":"10.1016\/j.semcancer.2017.07.007_bib0440","doi-asserted-by":"crossref","first-page":"5475","DOI":"10.1158\/0008-5472.CAN-10-0176","article-title":"FoxO1A is a target for HER2-overexpressing breast tumors","volume":"70","author":"Wu","year":"2010","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.semcancer.2017.07.007_bib0445","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10120-013-0314-2","article-title":"The forkhead transcription factor FoxO1 mediates cisplatin resistance in gastric cancer cells by activating phosphoinositide 3-kinase\/Akt pathway","volume":"17","author":"Park","year":"2014","journal-title":"Gastric Cancer"},{"issue":"41","key":"10.1016\/j.semcancer.2017.07.007_bib0450","doi-asserted-by":"crossref","first-page":"9141","DOI":"10.3748\/wjg.v22.i41.9141","article-title":"HER2-induced metastasis is mediated by Akt\/JNK\/EMT signaling pathway in gastric cancer","volume":"22","author":"Choi","year":"2016","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.semcancer.2017.07.007_bib0455","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/jcp.22011","article-title":"Src signaling in cancer invasion","volume":"223","author":"Guarino","year":"2010","journal-title":"J. Cell. Physiol."},{"issue":"3","key":"10.1016\/j.semcancer.2017.07.007_bib0460","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ccr.2004.09.001","article-title":"c-Src and cooperating partners in human cancer","volume":"6","author":"Ishizawar","year":"2004","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.semcancer.2017.07.007_bib0465","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1634\/theoncologist.2009-0009","article-title":"The role of Src in solid tumors","volume":"14","author":"Wheeler","year":"2009","journal-title":"Oncologist"},{"issue":"37","key":"10.1016\/j.semcancer.2017.07.007_bib0470","doi-asserted-by":"crossref","first-page":"4537","DOI":"10.1038\/onc.2013.416","article-title":"SRChing for the substrates of Src","volume":"33","author":"Reynolds","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2017.07.007_bib0475","doi-asserted-by":"crossref","first-page":"d501","DOI":"10.2741\/A208","article-title":"Role of c-Src tyrosine kinase in EGF-induced mitogenesis","volume":"2","author":"Belsches","year":"1997","journal-title":"Front. Biosci."},{"issue":"3","key":"10.1016\/j.semcancer.2017.07.007_bib0480","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.tips.2011.11.002","article-title":"Targeting Src family kinases in anti-cancer therapies: turning promise into triumph","volume":"33","author":"Zhang","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"issue":"11","key":"10.1016\/j.semcancer.2017.07.007_bib0485","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.bbamcr.2011.01.007","article-title":"Regulation of FoxO protein stability via ubiquitination and proteasome degradation","volume":"1813","author":"Huang","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.semcancer.2017.07.007_bib0490","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1038\/srep04048","article-title":"Src tyrosine kinase signaling antagonizes nuclear localization of FoxO and inhibits its transcription factor activity","volume":"4","author":"Bulow","year":"2014","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.semcancer.2017.07.007_bib0495","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s10585-004-4226-8","article-title":"SGK1, a potential regulator of c-fms related breast cancer aggressiveness","volume":"21","author":"Tangir","year":"2004","journal-title":"Clin. Exp. Metastasis"},{"issue":"3","key":"10.1016\/j.semcancer.2017.07.007_bib0500","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1007\/s13277-015-4119-2","article-title":"Antimetastatic effect of fluvastatin on breast and hepatocellular carcinoma cells in relation to SGK1 and NDRG1 genes","volume":"37","author":"Salis","year":"2016","journal-title":"Tumour Biol."},{"issue":"3","key":"10.1016\/j.semcancer.2017.07.007_bib0505","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1128\/MCB.21.3.952-965.2001","article-title":"Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FoxO3a)","volume":"21","author":"Brunet","year":"2001","journal-title":"Mol. Cell. Biol."},{"issue":"17","key":"10.1016\/j.semcancer.2017.07.007_bib0510","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1080\/15384101.2016.1194136","article-title":"SGK-1 and pH LPP1. ras-mediated effectors during ECM-detachment","volume":"15","author":"Mason","year":"2016","journal-title":"Cell Cycle (Georgetown Tex.)"},{"issue":"9","key":"10.1016\/j.semcancer.2017.07.007_bib0515","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1093\/carcin\/bgt163","article-title":"Metastasis suppressor, NDRG1, mediates its activity through signaling pathways and molecular motors","volume":"34","author":"Sun","year":"2013","journal-title":"Carcinogenesis"},{"issue":"11","key":"10.1016\/j.semcancer.2017.07.007_bib0520","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1096\/fj.03-0935fje","article-title":"Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis","volume":"18","author":"Darash-Yahana","year":"2004","journal-title":"FASEB J."},{"issue":"12","key":"10.1016\/j.semcancer.2017.07.007_bib0525","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1038\/labinvest.3700181","article-title":"CXCL12-CXCR4 interactions modulate prostate cancer cell migration, metalloproteinase expression and invasion","volume":"84","author":"Singh","year":"2004","journal-title":"Lab. Invest."},{"issue":"11","key":"10.1016\/j.semcancer.2017.07.007_bib0530","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1182\/blood.V94.11.3658","article-title":"Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells","volume":"94","author":"Burger","year":"1999","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.semcancer.2017.07.007_bib0535","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s00277-003-0679-0","article-title":"CXCR4 and SDF-1 expression in B-cell chronic lymphocytic leukemia and stage of the disease","volume":"82","author":"Barretina","year":"2003","journal-title":"Ann. Hematol."},{"issue":"2","key":"10.1016\/j.semcancer.2017.07.007_bib0540","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.canlet.2008.04.050","article-title":"The role of CXC chemokines and their receptors in cancer","volume":"267","author":"Vandercappellen","year":"2008","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.semcancer.2017.07.007_bib0545","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/path.2350","article-title":"New insights on the role of CXCR4 in cancer metastasis","volume":"215","author":"Zlotnik","year":"2008","journal-title":"J. Pathol."},{"issue":"7","key":"10.1016\/j.semcancer.2017.07.007_bib0550","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1440-1827.2010.02548.x","article-title":"CXCR4 and cancer","volume":"60","author":"Furusato","year":"2010","journal-title":"Pathol. Int."},{"issue":"2","key":"10.1016\/j.semcancer.2017.07.007_bib0555","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.canlet.2008.09.034","article-title":"CXCR4 mediates the proliferation of glioblastoma progenitor cells","volume":"274","author":"Ehtesham","year":"2009","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.semcancer.2017.07.007_bib0560","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1593\/neo.05694","article-title":"CXCR4 chemokine receptor mediates prostate tumor cell adhesion through alpha5 and beta3 integrins","volume":"8","author":"Engl","year":"2006","journal-title":"Neoplasia"},{"issue":"1","key":"10.1016\/j.semcancer.2017.07.007_bib0565","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/pros.20500","article-title":"Expression and activation of alpha v beta 3 integrins by SDF-1\/CXC12 increases the aggressiveness of prostate cancer cells","volume":"67","author":"Sun","year":"2007","journal-title":"Prostate"},{"issue":"3","key":"10.1016\/j.semcancer.2017.07.007_bib0570","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1677\/ERC-08-0019","article-title":"Integrins in prostate cancer progression","volume":"15","author":"Goel","year":"2008","journal-title":"Endocr. Relat. Cancer"},{"issue":"8","key":"10.1016\/j.semcancer.2017.07.007_bib0575","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1093\/carcin\/bgn108","article-title":"CXCL12\/CXCR4 promotes laryngeal and hypopharyngeal squamous cell carcinoma metastasis through MMP-13-dependent invasion via the ERK1\/2\/AP-1 pathway","volume":"29","author":"Tan","year":"2008","journal-title":"Carcinogenesis"},{"issue":"9","key":"10.1016\/j.semcancer.2017.07.007_bib0580","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1042\/CBI20100744","article-title":"Regulation of VEGF, MMP-9 and metastasis by CXCR4 in a prostate cancer cell line","volume":"35","author":"Wang","year":"2011","journal-title":"Cell Biol. Int."},{"issue":"2","key":"10.1016\/j.semcancer.2017.07.007_bib0585","doi-asserted-by":"crossref","first-page":"e31226","DOI":"10.1371\/journal.pone.0031226","article-title":"CXCR4 expression in prostate cancer progenitor cells","volume":"7","author":"Dubrovska","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.semcancer.2017.07.007_bib0590","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/boc.201100115","article-title":"MicroRNAs: critical regulators of epithelial to mesenchymal (EMT) and mesenchymal to epithelial transition (MET) in cancer progression","volume":"104","author":"Bullock","year":"2012","journal-title":"Biol. Cell"},{"issue":"6","key":"10.1016\/j.semcancer.2017.07.007_bib0595","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nrc822","article-title":"Epithelial-mesenchymal transitions in tumour progression","volume":"2","author":"Thiery","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcancer.2017.07.007_bib0600","doi-asserted-by":"crossref","first-page":"39001","DOI":"10.1038\/srep39001","article-title":"MiR-150 promotes cellular metastasis in non-small cell lung cancer by targeting FoxO4","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.semcancer.2017.07.007_bib0605","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.7314\/APJCP.2014.15.9.4013","article-title":"Low expression of the FoxO4 gene may contribute to the phenomenon of EMT in non-small cell lung cancer","volume":"15","author":"Xu","year":"2014","journal-title":"Asian Pac. J. Cancer Prev.: APJCP"},{"issue":"3","key":"10.1016\/j.semcancer.2017.07.007_bib0610","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1053\/j.gastro.2009.04.015","article-title":"ANXA8 down-regulation by EGF-FoxO4 signaling is involved in cell scattering and tumor metastasis of cholangiocarcinoma","volume":"137","author":"Lee","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semcancer.2017.07.007_bib0615","doi-asserted-by":"crossref","first-page":"5749749","DOI":"10.1155\/2016\/5749749","article-title":"Dynamics of actin stress fibers and focal adhesions during slow migration in swiss 3T3 fibroblasts: intracellular mechanism of cell turning","volume":"2016","author":"Sugawara","year":"2016","journal-title":"BioMed Res. Int."},{"issue":"7","key":"10.1016\/j.semcancer.2017.07.007_bib0620","doi-asserted-by":"crossref","first-page":"e101411","DOI":"10.1371\/journal.pone.0101411","article-title":"A genome-wide RNAi screen identifies FoxO4 as a metastasis-suppressor through counteracting PI3 K\/Akt signal pathway in prostate cancer","volume":"9","author":"Su","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.semcancer.2017.07.007_bib0625","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.18632\/oncotarget.6639","article-title":"Annexin A8 is a novel molecular marker for detecting lymph node metastasis in oral squamous cell carcinoma","volume":"7","author":"Oka","year":"2016","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.semcancer.2017.07.007_bib0630","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1093\/carcin\/bgr213","article-title":"MicroRNA-499-5p promotes cellular invasion and tumor metastasis in colorectal cancer by targeting FoxO4 and PDCD4","volume":"32","author":"Liu","year":"2011","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.semcancer.2017.07.007_bib0635","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3892\/mmr.2015.3362","article-title":"FoxO6 inhibits cell proliferation in lung carcinoma through up-regulation of USP7","volume":"12","author":"Hu","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"19","key":"10.1016\/j.semcancer.2017.07.007_bib0640","doi-asserted-by":"crossref","first-page":"31682","DOI":"10.18632\/oncotarget.15920","article-title":"Elevated FoxO6 expression correlates with progression and prognosis in gastric cancer","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.semcancer.2017.07.007_bib0645","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.canlet.2012.10.019","article-title":"MiR-429 is an independent prognostic factor in colorectal cancer and exerts its anti-apoptotic function by targeting SOX2","volume":"329","author":"Li","year":"2013","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.semcancer.2017.07.007_bib0650","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/jmcb\/mjr002","article-title":"SOX2 promotes tumorigenesis and increases the anti-apoptotic property of human prostate cancer cell","volume":"3","author":"Jia","year":"2011","journal-title":"J. Mol. Cell Biol."},{"issue":"11","key":"10.1016\/j.semcancer.2017.07.007_bib0655","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1038\/onc.2011.338","article-title":"Sox2 expression in breast tumours and activation in breast cancer stem cells","volume":"31","author":"Leis","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2017.07.007_bib0660","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.06132","article-title":"Inhibition of mutant EGFR in lung cancer cells triggers SOX2-FoxO6-dependent survival pathways","volume":"4","author":"Rothenberg","year":"2015","journal-title":"eLife"},{"issue":"1","key":"10.1016\/j.semcancer.2017.07.007_bib0665","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1530\/JOE-10-0480","article-title":"The diversity of sex steroid action: the role of micro-RNAs and FoxO transcription factors in cycling endometrium and cancer","volume":"212","author":"Lam","year":"2012","journal-title":"J. Endocrinol."},{"issue":"12","key":"10.1016\/j.semcancer.2017.07.007_bib0670","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1111\/bph.13471","article-title":"Posttranscriptional regulation of FoxO expression: microRNAs and beyond","volume":"174","author":"Urbanek","year":"2017","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.semcancer.2017.07.007_bib0675","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.bbrc.2015.02.160","article-title":"The role of microRNA-1274a in the tumorigenesis of gastric cancer: accelerating cancer cell proliferation and migration via directly targeting FoxO4","volume":"459","author":"Wang","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.semcancer.2017.07.007_bib0680","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12867-015-0052-6","article-title":"microRNA-150 promotes cervical cancer cell growth and survival by targeting FoxO4","volume":"16","author":"Li","year":"2015","journal-title":"BMC Mol. Biol."},{"issue":"1-2","key":"10.1016\/j.semcancer.2017.07.007_bib0685","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s11010-014-2281-2","article-title":"MiR-135b promotes proliferation and invasion of osteosarcoma cells via targeting FoxO1","volume":"400","author":"Pei","year":"2015","journal-title":"Mol. Cell. Biochem."},{"issue":"12","key":"10.1016\/j.semcancer.2017.07.007_bib0690","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.7150\/jca.13176","article-title":"MiR-182 is associated with growth, migration and invasion in prostate cancer via suppression of FoxO1","volume":"6","author":"Wallis","year":"2015","journal-title":"J. Cancer"},{"issue":"8","key":"10.1016\/j.semcancer.2017.07.007_bib0695","doi-asserted-by":"crossref","first-page":"10609","DOI":"10.1007\/s13277-016-4919-z","article-title":"MicroRNA-130b promotes proliferation and EMT-induced metastasis via PTEN\/p-Akt\/HIF-1alpha signaling","volume":"37","author":"Chang","year":"2016","journal-title":"Tumour Biol."},{"issue":"7 Pt A","key":"10.1016\/j.semcancer.2017.07.007_bib0700","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.bbamcr.2016.04.016","article-title":"miR-181b-3p promotes epithelial-mesenchymal transition in breast cancer cells through Snail stabilization by directly targeting YWHAG","volume":"1863","author":"Yoo","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.semcancer.2017.07.007_bib0705","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/hep.27221","article-title":"MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting pH domain and leucine-rich repeat protein phosphatase","volume":"60","author":"Chang","year":"2014","journal-title":"Hepatology"},{"issue":"42","key":"10.1016\/j.semcancer.2017.07.007_bib0710","doi-asserted-by":"crossref","first-page":"44222","DOI":"10.18632\/oncotarget.5826","article-title":"Foxo3a-mediated overexpression of microRNA-622 suppresses tumor metastasis by repressing hypoxia-inducible factor-1alpha in ERK-responsive lung cancer","volume":"6","author":"Cheng","year":"2015","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.semcancer.2017.07.007_bib0715","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/med.20139","article-title":"A FoxO in sight: targeting Foxo proteins from conception to cancer","volume":"29","author":"Maiese","year":"2009","journal-title":"Med. Res. Rev."},{"issue":"24","key":"10.1016\/j.semcancer.2017.07.007_bib0720","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.4161\/cc.7.24.7231","article-title":"Clever cancer strategies with FoxO transcription factors","volume":"7","author":"Maiese","year":"2008","journal-title":"Cell Cycle"},{"issue":"10","key":"10.1016\/j.semcancer.2017.07.007_bib0725","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nrc1189","article-title":"Cancer chemoprevention with dietary phytochemicals","volume":"3","author":"Surh","year":"2003","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.semcancer.2017.07.007_bib0730","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s12017-008-8037-y","article-title":"Hormetic dietary phytochemicals","volume":"10","author":"Son","year":"2008","journal-title":"Neuromolecular Med."},{"issue":"1","key":"10.1016\/j.semcancer.2017.07.007_bib0735","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s13277-013-1013-7","article-title":"Curcumin inhibits lung cancer progression and metastasis through induction of FoxO1","volume":"35","author":"Li","year":"2014","journal-title":"Tumour Biol."},{"issue":"12","key":"10.1016\/j.semcancer.2017.07.007_bib0740","doi-asserted-by":"crossref","first-page":"e15288","DOI":"10.1371\/journal.pone.0015288","article-title":"Resveratrol induces growth arrest and apoptosis through activation of FoxO transcription factors in prostate cancer cells","volume":"5","author":"Chen","year":"2010","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.semcancer.2017.07.007_bib0745","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1158\/1535-7163.MCT-13-0863","article-title":"CBP-mediated FoxO-1 acetylation inhibits pancreatic tumor growth by targeting SirT","volume":"13","author":"Pramanik","year":"2014","journal-title":"Mol. Cancer Ther."},{"issue":"1\u20132","key":"10.1016\/j.semcancer.2017.07.007_bib0750","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.mce.2008.04.018","article-title":"Phorbol 12-myristate 13-acetate inhibits FRO anaplastic human thyroid cancer cell proliferation by inducing cell cycle arrest in G1\/S phase: evidence for an effect mediated by PKCdelta","volume":"292","author":"Afrasiabi","year":"2008","journal-title":"Mol. Cell. Endocrinol."},{"issue":"2","key":"10.1016\/j.semcancer.2017.07.007_bib0755","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/carcin\/bgt316","article-title":"Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3\u202fK\/Akt\/FoxO pathway","volume":"35","author":"Shukla","year":"2014","journal-title":"Carcinogenesis"},{"issue":"7","key":"10.1016\/j.semcancer.2017.07.007_bib0760","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1158\/1078-0432.CCR-10-1891","article-title":"Pancreatic tumor suppression by benzyl isothiocyanate is associated with inhibition of PI3\u202fK\/Akt\/FoxO pathway","volume":"17","author":"Boreddy","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.semcancer.2017.07.007_bib0765","doi-asserted-by":"crossref","first-page":"e40152","DOI":"10.1371\/journal.pone.0040152","article-title":"An aqueous extract of Fagonia cretica induces DNA damage, cell cycle arrest and apoptosis in breast cancer cells via FoxO3a and p53 expression","volume":"7","author":"Lam","year":"2012","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.semcancer.2017.07.007_bib0770","doi-asserted-by":"crossref","first-page":"5763","DOI":"10.1158\/0008-5472.CAN-06-4327","article-title":"Activation of FoxO3a by the green tea polyphenol epigallocatechin-3-gallate induces estrogen receptor alpha expression reversing invasive phenotype of breast cancer cells","volume":"67","author":"Belguise","year":"2007","journal-title":"Cancer Res."},{"issue":"41","key":"10.1016\/j.semcancer.2017.07.007_bib0775","doi-asserted-by":"crossref","first-page":"27707","DOI":"10.1074\/jbc.M802759200","article-title":"Regulation of Akt\/FoxO3a\/GSK-3beta\/AR signaling network by isoflavone in prostate cancer cells","volume":"283","author":"Li","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.semcancer.2017.07.007_bib0780","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1002\/jcp.22920","article-title":"18beta-glycyrrhetinic acid induces apoptosis through modulation of Akt\/FoxO3a\/Bim pathway in human breast cancer MCF-7 cells","volume":"227","author":"Sharma","year":"2012","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.semcancer.2017.07.007_bib0785","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3892\/or.2012.2076","article-title":"Casticin induces growth suppression and cell cycle arrest through activation of FoxO3a in hepatocellular carcinoma","volume":"29","author":"He","year":"2013","journal-title":"Oncol. Rep."},{"issue":"3","key":"10.1016\/j.semcancer.2017.07.007_bib0790","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/ijc.23590","article-title":"Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells","volume":"123","author":"Kikuno","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.semcancer.2017.07.007_bib0795","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13046-015-0160-7","article-title":"Baicalein increases the expression and reciprocal interplay of RUNX3 and FoxO3a through crosstalk of AMPKalpha and MEK\/ERK1\/2 signaling pathways in human non-small cell lung cancer cells","volume":"34","author":"Zheng","year":"2015","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.semcancer.2017.07.007_bib0800","doi-asserted-by":"crossref","first-page":"860","DOI":"10.2174\/1568009614666141128104642","article-title":"Platycodin D induces tumor growth arrest by activating FoxO3a expression in prostate cancer in vitro and in vivo","volume":"14","author":"Zhou","year":"2015","journal-title":"Curr. Cancer Drug Targets"},{"issue":"3","key":"10.1016\/j.semcancer.2017.07.007_bib0805","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s10495-014-1071-3","article-title":"FoxO3-mediated up-regulation of Bim contributes to rhein-induced cancer cell apoptosis","volume":"20","author":"Wang","year":"2015","journal-title":"Apoptosis"},{"key":"10.1016\/j.semcancer.2017.07.007_bib0810","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s13046-015-0266-y","article-title":"Forkhead Box Transcription Factor (FoxO3a) mediates the cytotoxic effect of vernodalin in vitro and inhibits the breast tumor growth in vivo","volume":"34","author":"Ananda Sadagopan","year":"2015","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"19","key":"10.1016\/j.semcancer.2017.07.007_bib0815","doi-asserted-by":"crossref","first-page":"17832","DOI":"10.18632\/oncotarget.4026","article-title":"Ergosterol purified from medicinal mushroom Amauroderma rude inhibits cancer growth in vitro and in vivo by up-regulating multiple tumor suppressors","volume":"6","author":"Li","year":"2015","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.semcancer.2017.07.007_bib0820","doi-asserted-by":"crossref","first-page":"957","DOI":"10.3892\/ijmm.2015.2324","article-title":"Butein sensitizes HeLa cells to cisplatin through the Akt and ERK\/p38 MAPK pathways by targeting FoxO3a","volume":"36","author":"Zhang","year":"2015","journal-title":"Int. J. Mol. Med."},{"issue":"2","key":"10.1016\/j.semcancer.2017.07.007_bib0825","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/pros.22548","article-title":"Ardisianone, a natural benzoquinone, efficiently induces apoptosis in human hormone-refractory prostate cancers through mitochondrial damage stress and survivin downregulation","volume":"73","author":"Yu","year":"2013","journal-title":"Prostate"},{"key":"10.1016\/j.semcancer.2017.07.007_bib0830","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.freeradbiomed.2013.05.038","article-title":"A diterpenoid derivate compound targets selenocysteine of thioredoxin reductases and induces Bax\/Bak-independent apoptosis","volume":"63","author":"Liu","year":"2013","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.semcancer.2017.07.007_bib0835","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.taap.2012.09.022","article-title":"Isoorientin induces apoptosis through mitochondrial dysfunction and inhibition of PI3\u202fK\/Akt signaling pathway in HepG2 cancer cells","volume":"265","author":"Yuan","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"13","key":"10.1016\/j.semcancer.2017.07.007_bib0840","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1158\/0008-5472.CAN-13-0687","article-title":"Optimal targeting of HER2-PI3\u202fK signaling in breast cancer: mechanistic insights and clinical implications","volume":"73","author":"Rexer","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2017.07.007_bib0845","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1186\/1756-0500-6-507","article-title":"Pathologic complete response after preoperative anti-HER2 therapy correlates with alterations in PTEN FoxO, phosphorylated Stat5, and autophagy protein signaling","volume":"6","author":"Holmes","year":"2013","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.semcancer.2017.07.007_bib0850","unstructured":"G.A. Schott A, Perez R, Avery T, Kato G., Pilot Study to Evaluate Reparixin With Weekly Paclitaxel in Patients With HER 2 Negative Metastatic Breast Cancer ClinicalTrials.gov (2013) NCT02001974."}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X17300925?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X17300925?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T23:31:37Z","timestamp":1760916697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X17300925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":170,"alternative-id":["S1044579X17300925"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2017.07.007","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of Forkhead Box Class O proteins in cancer progression and metastasis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2017.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}